FDA hits Lupin, Aurobindo, Cipla with Form 483s
The FDA found issues related to cleanliness, out-of-specification results and more.
PhRMA lashes out against Pelosi drug pricing bill
The lobbying group has warned that Pelosi's bill to lower drug prices would have a “devastating” effect.
The lobbying group has warned that Pelosi's bill to lower drug prices would have a “devastating” effect.
FDA calls out Torrent as key contributor to major recall
The FDA has issued a warning letter to Torrent Pharmaceuticals.
Sanofi opens next-generation biologics plant in MA
Sanofi has now opened a new digital manufacturing facility in Framingham.
BeiGene builds China biopharma base
BeiGene announced the completion of Phase 1 of a more than 1,000,000 square foot bio facility.